{"transactions":[{"id":749405,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:10:13.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 100% on the first anniversary of the date of grant, subject to the director's continued service on such vesting date."}],"balance_after":20100,"derivative":{"exercise_price":13.96,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001247024-26-000004","document":"form4-06042026_040607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000124702426000004/form4-06042026_040607.xml","form_type":"4"}},{"id":824005,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-31T20:12:03.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":false,"shares":3166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":3167,"derivative":{"underlying":"Common Stock","underlying_shares":3166},"source":{"system":"sec-edgar","filing":"0001247024-26-000002","document":"form4-03312026_080359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000124702426000002/form4-03312026_080359.xml","form_type":"4"}},{"id":824004,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T20:12:03.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":3166,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":6333,"source":{"system":"sec-edgar","filing":"0001247024-26-000002","document":"form4-03312026_080359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000124702426000002/form4-03312026_080359.xml","form_type":"4"}},{"id":826450,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-27T20:44:50.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":53172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":53172},"source":{"system":"sec-edgar","filing":"0001193125-26-129239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526129239/ownership.xml","form_type":"4"}},{"id":826449,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-27T20:44:50.000Z","date":"2026-03-25","kind":"exercise","planned":false,"acquired":false,"shares":14295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":53172,"derivative":{"exercise_price":2.25,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":14295},"source":{"system":"sec-edgar","filing":"0001193125-26-129239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526129239/ownership.xml","form_type":"4"}},{"id":826448,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T20:44:50.000Z","date":"2026-03-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":53172,"price":37.7483,"value":2007152.6076,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.25 to $38.125. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":28231,"source":{"system":"sec-edgar","filing":"0001193125-26-129239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526129239/ownership.xml","form_type":"4"}},{"id":826447,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T20:44:50.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":53172,"price":2.25,"value":119637.0,"ownership":{"direct":true},"balance_after":81403,"source":{"system":"sec-edgar","filing":"0001193125-26-129239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526129239/ownership.xml","form_type":"4"}},{"id":826446,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T20:44:50.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":14295,"price":36.9714,"value":528506.163,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.95 to $37.11. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":28231,"source":{"system":"sec-edgar","filing":"0001193125-26-129239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526129239/ownership.xml","form_type":"4"}},{"id":826445,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T20:44:50.000Z","date":"2026-03-25","kind":"exercise","planned":false,"acquired":true,"shares":14295,"price":2.25,"value":32163.75,"ownership":{"direct":true},"balance_after":42526,"source":{"system":"sec-edgar","filing":"0001193125-26-129239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526129239/ownership.xml","form_type":"4"}},{"id":1105144,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:42:47.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":9568,"price":9.7822,"value":93596.0896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.55 to $9.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":28231,"source":{"system":"sec-edgar","filing":"0000950170-25-088602","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025088602/ownership.xml","form_type":"4"}},{"id":1105143,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T21:42:47.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":10,"price":10.35,"value":103.5,"ownership":{"direct":true},"balance_after":37799,"source":{"system":"sec-edgar","filing":"0000950170-25-088602","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025088602/ownership.xml","form_type":"4"}},{"id":1106080,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:30:15.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date."}],"balance_after":20100,"derivative":{"exercise_price":4.47,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001578563-25-000322","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856325000322/primary_doc.xml","form_type":"4"}},{"id":1109928,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T23:05:27.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":6814,"price":10.3795,"value":70725.913,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.35 to $10.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":37809,"source":{"system":"sec-edgar","filing":"0000950170-25-086960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025086960/ownership.xml","form_type":"4"}},{"id":1109927,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T23:05:27.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":10.3055,"value":154582.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":44623,"source":{"system":"sec-edgar","filing":"0000950170-25-086960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025086960/ownership.xml","form_type":"4"}},{"id":1109926,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T23:05:27.000Z","date":"2025-06-12","kind":"sale","planned":false,"acquired":false,"shares":30000,"price":10.3085,"value":309255.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":59623,"source":{"system":"sec-edgar","filing":"0000950170-25-086960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025086960/ownership.xml","form_type":"4"}},{"id":1127826,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T20:05:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":22200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 29, 2025, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":22200,"derivative":{"exercise_price":9.25,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":22200},"source":{"system":"sec-edgar","filing":"0000950170-25-080226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017025080226/ownership.xml","form_type":"4"}},{"id":1186180,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T20:30:23.000Z","date":"2025-03-28","kind":"exercise","planned":false,"acquired":false,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":6333,"derivative":{"underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0001578563-25-000200","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856325000200/primary_doc.xml","form_type":"4"}},{"id":1186179,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T20:30:23.000Z","date":"2025-03-28","kind":"exercise","planned":false,"acquired":true,"shares":3167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":3167,"source":{"system":"sec-edgar","filing":"0001578563-25-000200","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856325000200/primary_doc.xml","form_type":"4"}},{"id":1433492,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-14T20:19:19.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock upon the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":9500,"derivative":{"underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001578563-24-000365","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856324000365/primary_doc.xml","form_type":"4"}},{"id":1433491,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T20:19:19.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":24600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":24600,"derivative":{"exercise_price":9.88,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":24600},"source":{"system":"sec-edgar","filing":"0001578563-24-000365","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856324000365/primary_doc.xml","form_type":"4"}},{"id":1475618,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T21:01:27.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":false,"shares":61392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.61,"expiration_date":"2030-01-26","underlying":"Common Stock","underlying_shares":61392},"source":{"system":"sec-edgar","filing":"0000950170-24-074996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024074996/ownership.xml","form_type":"4"}},{"id":1475617,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T21:01:27.000Z","date":"2024-06-13","kind":"exercise","planned":false,"acquired":true,"shares":61392,"price":0.61,"value":37449.12,"ownership":{"direct":true},"balance_after":89623,"source":{"system":"sec-edgar","filing":"0000950170-24-074996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024074996/ownership.xml","form_type":"4"}},{"id":1496807,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-31T20:30:06.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 29, 2024, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":18600,"derivative":{"exercise_price":15.94,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0000950170-24-067354","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000095017024067354/ownership.xml","form_type":"4"}},{"id":1702029,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-21T21:03:05.000Z","date":"2023-12-20","kind":"grant","planned":false,"acquired":true,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option will vest in full on December 20, 2024, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":3334,"derivative":{"exercise_price":0.043,"exercise_date":"2024-12-20","expiration_date":"2033-12-20","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001628280-23-042491","document":"wk-form4_1703192576.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000162828023042491/wk-form4_1703192576.xml","form_type":"4"}},{"id":1870272,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-02T20:31:56.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 31, 2023, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":14500,"derivative":{"exercise_price":14.47,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001209191-23-033788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919123033788/doc4.xml","form_type":"4"}},{"id":2147113,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-03T20:25:51.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":3080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the stock option will immediately vest on the date that it is granted."}],"balance_after":3080,"derivative":{"exercise_price":3.32,"exercise_date":"2022-09-30","expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":3080},"source":{"system":"sec-edgar","filing":"0001628280-22-025857","document":"wf-form4_166482872994312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000162828022025857/wf-form4_166482872994312.xml","form_type":"4"}},{"id":2216917,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T20:07:24.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":44115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the stock option will immediately vest on the date that it is granted."}],"balance_after":44115,"derivative":{"exercise_price":0.5,"exercise_date":"2022-06-30","expiration_date":"2032-06-30","underlying":"Common Stock","underlying_shares":44115},"source":{"system":"sec-edgar","filing":"0001578563-22-000025","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856322000025/primary_doc.xml","form_type":"4"}},{"id":2231612,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T20:43:53.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following June 13, 2022, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders,  subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":14500,"derivative":{"exercise_price":5.38,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001209191-22-036971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000120919122036971/doc4.xml","form_type":"4"}},{"id":2231294,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T20:30:30.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option will vest in full on June 14, 2023, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.441,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001578563-22-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856322000022/primary_doc.xml","form_type":"4"}},{"id":2307769,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T21:37:53.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":30359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the stock option will immediately vest on the date that it is granted."}],"balance_after":30359,"derivative":{"exercise_price":0.7247,"exercise_date":"2022-03-31","expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":30359},"source":{"system":"sec-edgar","filing":"0001578563-22-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000157856322000010/primary_doc.xml","form_type":"4"}},{"id":2448128,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T21:23:24.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":12767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":12767,"derivative":{"exercise_price":1.7,"exercise_date":"2021-12-31","expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":12767},"source":{"system":"sec-edgar","filing":"0001062993-22-000242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000106299322000242/form4.xml","form_type":"4"}},{"id":2551614,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-04T20:33:52.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":9541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":9541,"derivative":{"exercise_price":2.18,"exercise_date":"2021-09-30","expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":9541},"source":{"system":"sec-edgar","filing":"0001878894-21-000005","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000187889421000005/edgar.xml","form_type":"4"}},{"id":2644071,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:14:39.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":6353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":6353,"derivative":{"exercise_price":3.27,"exercise_date":"2021-06-30","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":6353},"source":{"system":"sec-edgar","filing":"0001192482-21-000605","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000119248221000605/edgar.xml","form_type":"4"}},{"id":2663258,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T20:28:00.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option will be fully vested and exercisable on June 15, 2022, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.56,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001192482-21-000516","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000119248221000516/edgar.xml","form_type":"4"}},{"id":2760770,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T20:10:42.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":7650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":7650,"derivative":{"exercise_price":3.02,"exercise_date":"2021-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001247024-21-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000124702421000010/edgar.xml","form_type":"4"}},{"id":2919889,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T21:20:19.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":7216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":7216,"derivative":{"exercise_price":2.64,"exercise_date":"2020-12-31","expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":7216},"source":{"system":"sec-edgar","filing":"0001192482-21-000036","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000119248221000036/edgar.xml","form_type":"4"}},{"id":3008043,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T12:04:07.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in three substantially equal installments on October 8, 2021, 2022 and 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.45,"expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-20-000774","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1247024/000119248220000774/edgar.xml","form_type":"4"}},{"id":3924997,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-21T16:15:15.000Z","date":"2018-05-18","kind":"exercise","acquired":false,"shares":27750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":30.01,"expiration_date":"2018-06-18","underlying":"Common Stock","underlying_shares":27750},"source":{"system":"sec-edgar","filing":"0001415889-18-000791","document":"form4-05212018_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000791/form4-05212018_040501.xml","form_type":"4"}},{"id":3924996,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T16:15:15.000Z","date":"2018-05-18","kind":"sale","acquired":false,"shares":27750,"price":78.6576,"value":2182748.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $78.62 to $78.74, inclusive. The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":76301,"source":{"system":"sec-edgar","filing":"0001415889-18-000791","document":"form4-05212018_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000791/form4-05212018_040501.xml","form_type":"4"}},{"id":3924995,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-21T16:15:15.000Z","date":"2018-05-18","kind":"exercise","acquired":true,"shares":27750,"price":30.01,"value":832777.5,"ownership":{"direct":true},"balance_after":104051,"source":{"system":"sec-edgar","filing":"0001415889-18-000791","document":"form4-05212018_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000791/form4-05212018_040501.xml","form_type":"4"}},{"id":4049724,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-20T17:02:42.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":27.18,"expiration_date":"2018-03-17","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-18-011403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118011403/doc4.xml","form_type":"4"}},{"id":4049723,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-20T17:02:42.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":9250,"price":94.83,"value":877177.5,"ownership":{"direct":true},"balance_after":76301,"source":{"system":"sec-edgar","filing":"0001209191-18-011403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118011403/doc4.xml","form_type":"4"}},{"id":4049722,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-20T17:02:42.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":9250,"price":95.989,"value":887898.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $95.987 to $96.00, inclusive. The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":85551,"source":{"system":"sec-edgar","filing":"0001209191-18-011403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118011403/doc4.xml","form_type":"4"}},{"id":4049721,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-20T17:02:42.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":9250,"price":27.18,"value":251415.0,"ownership":{"direct":true},"balance_after":94801,"source":{"system":"sec-edgar","filing":"0001209191-18-011403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919118011403/doc4.xml","form_type":"4"}},{"id":4140956,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-06T16:45:34.000Z","date":"2017-12-05","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.965,"expiration_date":"2017-12-17","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-17-064199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117064199/doc4.xml","form_type":"4"}},{"id":4140955,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-06T16:45:34.000Z","date":"2017-12-05","kind":"exercise","acquired":true,"shares":9250,"price":24.965,"value":230926.25,"ownership":{"direct":true},"balance_after":85551,"source":{"system":"sec-edgar","filing":"0001209191-17-064199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117064199/doc4.xml","form_type":"4"}},{"id":4209785,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-14T16:35:09.000Z","date":"2017-09-12","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":33.88,"expiration_date":"2017-09-17","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-17-052820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117052820/doc4.xml","form_type":"4"}},{"id":4209784,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-14T16:35:09.000Z","date":"2017-09-12","kind":"sale","acquired":false,"shares":9250,"price":141.56,"value":1309430.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $141.45 to $141.61, inclusive. The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":76301,"source":{"system":"sec-edgar","filing":"0001209191-17-052820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117052820/doc4.xml","form_type":"4"}},{"id":4209783,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-14T16:35:09.000Z","date":"2017-09-12","kind":"exercise","acquired":true,"shares":9250,"price":33.88,"value":313390.0,"ownership":{"direct":true},"balance_after":85551,"source":{"system":"sec-edgar","filing":"0001209191-17-052820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117052820/doc4.xml","form_type":"4"}},{"id":4244719,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-03T16:45:35.000Z","date":"2017-08-02","kind":"sale","acquired":false,"shares":7500,"price":134.52,"value":1008900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $134.46 to $134.54, inclusive. The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":76301,"source":{"system":"sec-edgar","filing":"0001209191-17-047380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117047380/doc4.xml","form_type":"4"}},{"id":4266271,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-07-05T19:32:27.000Z","date":"2017-07-01","kind":"exercise","acquired":false,"shares":734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":734},"source":{"system":"sec-edgar","filing":"0001209191-17-043765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117043765/doc4.xml","form_type":"4"}},{"id":4266270,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T19:32:27.000Z","date":"2017-07-01","kind":"exercise","acquired":true,"shares":734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and such vested portion of the restricted stock units settled for shares of the Company's common stock."}],"balance_after":83801,"source":{"system":"sec-edgar","filing":"0001209191-17-043765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117043765/doc4.xml","form_type":"4"}},{"id":4276707,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-06-20T16:08:20.000Z","date":"2017-06-17","kind":"exercise","acquired":false,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The balance of the restricted stock units will vest on June 17, 2018.  Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015))."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":334,"derivative":{"underlying":"Common Stock","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001209191-17-041067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041067/doc4.xml","form_type":"4"}},{"id":4276706,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-20T16:08:20.000Z","date":"2017-06-17","kind":"exercise","acquired":true,"shares":333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock."}],"balance_after":83067,"source":{"system":"sec-edgar","filing":"0001209191-17-041067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117041067/doc4.xml","form_type":"4"}},{"id":4279967,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-06-16T16:09:46.000Z","date":"2017-06-15","kind":"exercise","acquired":false,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The remainder of the restricted stock units will vest as follows: 375 shares on June 15, 2018; 375 shares on June 15, 2019. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":750,"derivative":{"underlying":"Common Stock","underlying_shares":375},"source":{"system":"sec-edgar","filing":"0001209191-17-040459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040459/doc4.xml","form_type":"4"}},{"id":4279966,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-06-16T16:09:46.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units will vest in three equal annual installments commencing on June 14, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units will vest in three equal annual installments commencing on June 14, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":900,"derivative":{"underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001209191-17-040459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040459/doc4.xml","form_type":"4"}},{"id":4279965,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-16T16:09:46.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option is immediately exercisable and will vest on the earlier of June 14, 2018 or the day preceding the date of the next annual stockholder meeting."}],"balance_after":10500,"derivative":{"exercise_price":121.04,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-17-040459","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040459/doc4.xml","form_type":"4"}},{"id":4279964,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-16T16:09:46.000Z","date":"2017-06-15","kind":"exercise","acquired":true,"shares":375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"One-third of the restricted stock units granted to the reporting person on June 15, 2016 vested and settled for shares of the Company's common stock."}],"balance_after":82734,"source":{"system":"sec-edgar","filing":"0001209191-17-040459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117040459/doc4.xml","form_type":"4"}},{"id":4297077,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-02T16:11:45.000Z","date":"2017-06-01","kind":"exercise","acquired":false,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":28.965,"expiration_date":"2017-06-12","underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0001209191-17-037189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117037189/doc4.xml","form_type":"4"}},{"id":4297076,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-02T16:11:45.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":9250,"price":28.965,"value":267926.25,"ownership":{"direct":true},"balance_after":82359,"source":{"system":"sec-edgar","filing":"0001209191-17-037189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117037189/doc4.xml","form_type":"4"}},{"id":4367507,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-31T17:31:56.000Z","date":"2017-03-30","kind":"sale","acquired":false,"shares":14033,"price":123.83,"value":1737706.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $123.76 to $123.92, inclusive.  The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":73109,"source":{"system":"sec-edgar","filing":"0001209191-17-023918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117023918/doc4.xml","form_type":"4"}},{"id":4398980,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-03-07T16:37:10.000Z","date":"2017-03-03","kind":"exercise","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":25.575,"expiration_date":"2017-03-15","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-018752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117018752/doc4.xml","form_type":"4"}},{"id":4398979,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-07T16:37:10.000Z","date":"2017-03-03","kind":"exercise","acquired":true,"shares":7500,"price":25.575,"value":191812.5,"ownership":{"direct":true},"balance_after":87142,"source":{"system":"sec-edgar","filing":"0001209191-17-018752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919117018752/doc4.xml","form_type":"4"}},{"id":4599428,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-09-20T16:42:27.000Z","date":"2016-09-19","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 1995 Non-Employee Director's Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":29.26,"expiration_date":"2016-12-15","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-16-142165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919116142165/doc4.xml","form_type":"4"}},{"id":4599427,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-20T16:42:27.000Z","date":"2016-09-19","kind":"exercise","acquired":true,"shares":7500,"price":29.26,"value":219450.0,"ownership":{"direct":true},"balance_after":79642,"source":{"system":"sec-edgar","filing":"0001209191-16-142165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919116142165/doc4.xml","form_type":"4"}},{"id":4602084,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":41289,"kind":"person","name":"KAPLAN GILLA","position":1,"cik":"0001247024","reported_name":"KAPLAN GILLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T16:15:59.000Z","date":"2016-09-15","kind":"sale","acquired":false,"shares":9710,"price":106.44,"value":1033532.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold by the reporting person in multiple transactions at prices ranging from $106.26 to $106.66, inclusive.  The reporting person undertakes to provide to Celgene Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":72142,"source":{"system":"sec-edgar","filing":"0001209191-16-141774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000120919116141774/doc4.xml","form_type":"4"}}]}